156 related articles for article (PubMed ID: 10037169)
1. Colorectal cancer as a model for immunotherapy.
Foon KA; Yannelli J; Bhattacharya-Chatterjee M
Clin Cancer Res; 1999 Feb; 5(2):225-36. PubMed ID: 10037169
[No Abstract] [Full Text] [Related]
2. The anti-idiotype vaccines for immunotherapy.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Curr Opin Mol Ther; 2001 Feb; 3(1):63-9. PubMed ID: 11249733
[TBL] [Abstract][Full Text] [Related]
3. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
[No Abstract] [Full Text] [Related]
4. Current concepts in immunotherapy for the treatment of colorectal cancer.
Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for colorectal cancer.
Foon KA
Curr Oncol Rep; 2001 Mar; 3(2):116-26. PubMed ID: 11177743
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced apoptosis: a novel clinical trial end point?
Amin S; Robins RA; Maxwell-Armstrong CA; Scholefield JH; Durrant LG
Cancer Res; 2000 Jun; 60(12):3132-6. PubMed ID: 10866299
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for colorectal cancer.
Midgley RS; Kerr DJ
Expert Rev Anticancer Ther; 2003 Feb; 3(1):63-78. PubMed ID: 12597351
[TBL] [Abstract][Full Text] [Related]
8. Active specific immunotherapy for colorectal cancer.
Indar AA; Maxwell-Armstrong CA
Expert Rev Anticancer Ther; 2003 Oct; 3(5):685-94. PubMed ID: 14599091
[TBL] [Abstract][Full Text] [Related]
9. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ
Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
Kerr DJ; Midgley RS
Semin Oncol; 2000 Oct; 27(5 Suppl 10):132-7. PubMed ID: 11049045
[No Abstract] [Full Text] [Related]
11. Developing effective cancer vaccines: design and monitoring are critical.
Armstrong A; Dermime S
Br J Cancer; 2001 Jun; 84(11):1433-6. PubMed ID: 11384088
[No Abstract] [Full Text] [Related]
12. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
Ullenhag GJ; Spendlove I; Watson NF; Indar AA; Dube M; Robins RA; Maxwell-Armstrong C; Scholefield JH; Durrant LG
Clin Cancer Res; 2006 Dec; 12(24):7389-96. PubMed ID: 17121873
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.
Denton GW; Durrant LG; Hardcastle JD; Austin EB; Sewell HF; Robins RA
Int J Cancer; 1994 Apr; 57(1):10-4. PubMed ID: 8150527
[TBL] [Abstract][Full Text] [Related]
14. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.
Moulton HM; Yoshihara PH; Mason DH; Iversen PL; Triozzi PL
Clin Cancer Res; 2002 Jul; 8(7):2044-51. PubMed ID: 12114402
[TBL] [Abstract][Full Text] [Related]
15. Vaccines in lymphoma.
Levy R
Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
[No Abstract] [Full Text] [Related]
16. Technology evaluation: Onyvax-105, Onyvax.
Blumenthal RD
Curr Opin Mol Ther; 2003 Dec; 5(6):668-72. PubMed ID: 14755894
[TBL] [Abstract][Full Text] [Related]
17. The immunology of colorectal cancer.
Zbar AP
Surg Oncol; 2004; 13(2-3):45-53. PubMed ID: 15572086
[TBL] [Abstract][Full Text] [Related]
18. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies.
Atreya I; Neurath MF
Expert Rev Anticancer Ther; 2008 Apr; 8(4):561-72. PubMed ID: 18402523
[TBL] [Abstract][Full Text] [Related]
19. Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer.
Maxwell-Armstrong CA; Durrant LG; Buckley TJ; Scholefield JH; Robins RA; Fielding K; Monson JR; Guillou P; Calvert H; Carmichael J; Hardcastle JD
Br J Cancer; 2001 Jun; 84(11):1443-6. PubMed ID: 11384090
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1.
Koda K; Glassy MC; McKnight ME; Yasutomi J; Saito N; Dan M; Nakajima N
Anticancer Res; 2001; 21(1B):621-7. PubMed ID: 11299816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
